title: The Safety and Efficacy of Narrow Band Ultraviolet B Treatment in Dermatology: A Review.
abstract: Narrow-band ultraviolet B (NBUVB) phototherapy is an important treatment modality in dermatology. The most common dermatological indications for NBUVB include psoriasis, atopic dermatitis and vitiligo; however, it has been found to be an effective and well-tolerated treatment option in various other dermatoses. The efficacy of NBUVB phototherapy compares favorably with other available photo(chemo)therapy options and its efficacy is further augmented by a number of topical and systemic adjuncts. The long-term safety of NBUVB phototherapy remains to be fully elucidated; however, available data now suggest that it is safe and well-tolerated. The objective of this review was to summarize the current understanding of the safety and efficacy of NBUVB phototherapy in dermatology.
authors.affiliation: Westmead Hospital, Cnr Hawkesbury Road and Darcy Road, Westmead, NSW, 2145, Australia.
authors.forename: Anna
authors.initials: A
authors.lastname: Sokolova
authors.affiliation: Department of Dermatology, Royal North Shore Hospital, Reserve Road, St Leonards, NSW, 2065, Australia. a.lee@sydney.edu.au.|Northern Clinical School, The University of Sydney, Sydney, NSW, Australia. a.lee@sydney.edu.au.
authors.forename: Andrew
authors.initials: A
authors.lastname: Lee
authors.affiliation: Department of Dermatology, Royal North Shore Hospital, Reserve Road, St Leonards, NSW, 2065, Australia.|Northern Clinical School, The University of Sydney, Sydney, NSW, Australia.
authors.forename: Saxon
authors.initials: S
authors.lastname: D Smith
mesh_terms: D000328:Adult; D000367:Age Factors; D002648:Child; D003876:Dermatitis, Atopic / Q000175:diagnosis / Q000532:radiotherapy*; D003880:Dermatology / Q000379:methods / Q000639:trends; D005260:Female; D006801:Humans; D008297:Male; D061214:Patient Safety; D017410:Practice Guidelines as Topic; D011379:Prognosis; D011565:Psoriasis / Q000175:diagnosis / Q000532:radiotherapy*; D011879:Radiotherapy Dosage; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D016896:Treatment Outcome; D014467:Ultraviolet Therapy / Q000009:adverse effects / Q000379:methods*; D014820:Vitiligo / Q000175:diagnosis / Q000532:radiotherapy*